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Abstract
Background: Atrial fibrillation (AF) is a common cardiac arrhythmia and increases risk of ischemic stroke. Data on
the prevalence of AF in Thailand is lacking especially in patients with hypertension. The objectives of this study
were to determine prevalence of AF in patients with hypertension and to determine factors that are associated
with increased prevalence of AF in a multicenter nationwide study.
Methods: A cross-sectional survey for the national outcome evaluation among hypertensive patients visiting 831
public hospitals in Thailand was conducted between 2011 and 2012 to evaluate status of standard care in
hypertensive patients visiting public Thailand Ministry of Public Health (MoPH) hospitals. Inclusion criteria were
hypertensive patients aged at least 20 years who had received medical care in the targeted hospital for at
least 12 months. The main outcome measurement was AF rhythm, and was measured along with potential
risk factors age, gender and cardiovascular risk factors.
Results: There were 13207 hypertensive patients who had ECG data recorded during the survey. AF was
detected in 457 patients (3.46 %). Prevalence of AF increased with increasing age, was more common in
males and in patients with chronic kidney disease (CKD). Multivariable modelling was conducted to assess
which factors were most associated with increased prevalence of AF, and the results showed older age
followed by male gender, low LDL-cholesterol and increased uric acid levels were the most important risk
factors for AF in this population.
Conclusions: Prevalence of AF in hypertensive patients was 3.46 %. Factors associated with increased risk of
AF are old age, male gender, low LDL-cholesterol and elevated uric acid level.
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Background
Atrial fibrillation (AF) is the most common sustained
cardiac arrhythmia [1, 2]. The prevalence and incidence
increases with age and is more prevalent in men than
women [2]. It is estimated that the prevalence of AF is
approximately 1–2 % [3]. Prevalence of AF in Asian
countries has been reported to be slightly lower than in
western populations [4–6]. However, due to the much
larger population size of Asia, the burden of AF has
been estimated to be much larger in the Asian popula-
tion compared to western countries. It is estimated that
approximately 49 million men and 23 million women in
Asia will suffer from AF in 2050 [7]. This number is
roughly 12 times more than current estimates in United
States [8]. AF may be classified as valvular and non-
valvular in origin. Majority of AF are non-valvular eti-
ology [3]. Prevalence of AF increases in patients with
certain risk factors such as hypertension [9, 10]. Hyper-
tension increases risk of AF by approximately 1.5 fold in
both men and women and is likely to be the most im-
portant risk factor for developing AF [11].
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Non-valvular AF is an important cause of ischemic
stroke both in western and Asian population [5, 12]. The
annual incidence of ischemic stroke in patients with non-
valvular AF has been reported to be around 5 % [5, 12].
There are many risk factors for ischemic stroke in patients
with non-valvular AF such as diabetes mellitus, systemic
hypertension, old age, heart failure or left ventricular dys-
function, along with a history of ischemic stroke or transi-
ent ischemic attack (TIA) [6, 9, 10].
Prevalence of AF in Asian population has been re-
ported from many countries such as China [5, 13], Japan
[14], Korea [15], Taiwan [5], and Singapore [16]. There
are limited data for the prevalence of AF in Thailand,
both in the general population and in patients with risk
factors such as hypertension. We sought to determine
the prevalence of AF in patients with hypertension
among a large nationwide cross-sectional study in
patients with hypertension. Secondary objectives of this
study were 1) to determine the prevalence of AF in
patients with hypertension stratified by age and gender
and 2) to determine factors associated with AF.
Methods
Study population
A cross-sectional survey for the national outcome evalu-
ation among hypertensive patients visiting public hospi-
tals in Thailand was conducted between 2011 and 2012
to evaluate status of standard care in hypertensive pa-
tients visiting public Thailand Ministry of Public Health
(MoPH) hospitals in Thailand including private clinics
in the Thailand National Health Security Office
(NHSO)’s program in Bangkok. Inclusion criteria for the
present study were hypertensive patients aged at least
20 years old who received medical care in the participat-
ing hospital for the previous 12 months. Patients partici-
pating in clinical trials were excluded.
A two-stage stratified cluster, proportional to the size
sampling technique was used to select a nationally and pro-
vincially representative sample of hypertensive patients in
Thailand. For every province outside Bangkok, the targeted
hospital included all hospitals that were public hospitals
under the MoPH. For Bangkok, the targeted hospital in-
cluded all hospitals and clinics participating in the Thailand
NHSO’s program. The first stage of sampling was at the
province level representing 77 strata, and the second stage
of sampling was the level of hospital in each province in
Thailand. Hospitals in each province were stratified into 5
strata by their sizes i.e., regional center hospital (>500 beds),
provincial general hospital (200 – 500 beds), large commu-
nity hospital (90 – 120 beds), medium community hospital
(60 beds), and small community hospital (10 – 30 beds).
All university hospitals were excluded from our study.
The study was approved by the Ethical Review Com-
mittee for Research in Human Subjects, Thailand
Ministry of Public Health, and the Royal Thai Army
Medical Department Ethical Review Board as well as
local institutional review boards of the participating
hospitals. Written informed consent was obtained prior
to participation.
Data collection
There were a total of 831 hospitals under the Thai uni-
versal coverage scheme: 25 regional hospitals, 70 general
hospitals and 736 community hospitals. All regional and
general hospitals were selected as well as 70 % of small
community hospital, 20 % of medium size community
hospital and 10 % of large community hospital. This fac-
tion was based on the proportion of patient care under-
taken at the various levels of hospitals. Patients with
diagnosis of hypertension were randomly selected ac-
cording to the proportion of patients registered at each
hospital. Sample size of study population was calculated
from the proportion to size model for each province.
Data were retrieved from patients’ medical records
and included baseline information, status of hypertensive
complication, and results of laboratory tests.
Measurements
Collected variables were demographic data, weight,
height, body mass index (BMI), systolic blood pressure
(SBP), diastolic blood pressure (DBP), cardiovascular risk
factors, blood chemistry data including fasting plasma
glucose (FPG), serum creatinine, uric acid, lipid profiles,
available ECG data and results, and complication related
to hypertension including stroke. Glomerular filtration
rate (GFR) was calculated from epidemiology collabor-
ation formula (EPI). Stroke was classified as ischemic
stroke, TIA, unspecified stroke, hemorrhagic stroke.
Data management team sent query to study site to verify
data if needed. Data and site monitoring was performed in
10 % of study site or approximately 60 hospitals by a
random selection process.
ECG is not a prerequisite for the main study. It was
noted in the case record form (CRF) whether there were
ECG data in the medical record. For those who had
ECG, results of the ECG interpretation were recorded.
Cardiac rhythm was noted for the presence or absence
of AF.
Main outcome measurements include AF rhythm and
factors that might be related to AF such as age, gender,
cardiovascular risk factors.
Statistical analysis
Continuous data were presented as mean and standard
deviation while categorical variables were presented as
number and percentages. Prevalence data was reported
as percentage and 95 % confidence interval. Compari-
sons of continuous data were made by an independent
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sample t-test. For categorical variables, comparisons
were made by the chi-square test. Continuous data were
grouped for the analysis of Odds ratio as follows;
age ≥ 65 years, SBP ≥ 140 mmHg, DBP ≥ 90 mmHg,
TC ≥ 200 mg/dl, TG ≥ 200 mg/dl, HDL < 40 mg/dl,
LDL ≥ 100 mg/dl, BMI ≥ 25 kg/m2, GFR < 60 ml/min,
uric acid ≥ 7 mg/dl in male and ≥ 6 mg/dl in female.
Odds ratio and 95 % confidence interval (CI) for uni-
variate analysis were made by the Likelihood ratio
test. Multivariate logistic regression analysis (with for-
ward LR) was performed to determine the independ-
ent factors associated with increased risk of AF using
complete-cases analysis and imputation method for
the missing data. Missing values were imputed based
on the means of complete cases with noise added
based on the t-distribution. A p-value less than 0.05
was considered significant. Statistical analysis was per-
formed with SPSS version 20.
Results
There were a total of 71440 with hypertension en-
rolled in the main study during 2011–2012. ECG was
performed in 13207 patients (18.5 %). Average age
was 63.6 ± 11.1 years, 4711 (35.7 %) were male. Base-
line variables between patients with and without ECG
were numerically similar for SBP (130.8 ± 16.3 vs
129.9 ± 16.0 mmHg), DBP (75.0 ± 10.8 vs 75.4 ±
10.5 mmHg), FPG (116.2 ± 40.4 vs 120.3 ± 43.1 mg/dl),
serum creatinine (1.17 ± 0.87 vs 1.17 ± 1.10 mg/dl),
total cholesterol (190.7 ± 44.1 vs 192.5 ± 44.2 mg/dl),
triglyceride (158.2 ± 92.8 vs 163.7 ± 100.4 mg/dl),
HDL-cholesterol (47.8 ± 13.7 vs 48.0 ± 14.3 mg/dl) and
LDL-cholesterol (113.5 ± 37.4 vs 114.2 ± 37.3 mg/dl)
with a slightly older age for patients who had ECG
(63.6 ± 11.1 vs 61.1 ± 11.2 years) and greater propor-
tion of male (35.7 vs 33.7 %).
Among 13207 patients with available ECG, AF was de-
tected in 457 patients (3.46 %, 95 % CI 3.16-3.79). Baseline
characteristics between patients with and without AF are
shown in Table 1. Prevalence of AF increased with in-
creasing age, more common in male and in patients with
chronic kidney disease (CKD). Figure 1 showed the bar
graph of prevalence of AF for every 10-year of age and
separate between men and women. Since the increased
prevalence of AF in males was evident only until the 7th
decade of life and the prevalence in individuals ≥ 70 years
was roughly the same in men and women, we performed
additional analysis for interaction between age and gender
on the prevalence of AF. The results showed that there
was a significant interaction (p for interaction test <0.001)
between age and gender on the association of AF.
We did not collect the data on antihypertensive medi-
cations except for angiotensin converting enzyme inhibi-
tor (ACEI) or angiotensin receptor blocker (ARB) due to
the special interest on the use of this drug group in
Asian population. ACEI or ARB was prescribed in 2838
patients (21.5 %). There was no significant association
between ACEI or ARB and AF (prevalence of AF was
3.0 % in patients with ACEI or ARB and 3.6 % in those
without, p = 0.157).
Figure 2 showed bivariate analysis of demographic
data, and cardiovascular risk factors in relation to the
prevalence of AF including Odds ratio and 95 % CI. Fac-
tors that were associated with increased risk of AF at the
p value < 0.10 from univariate analysis were old age,
male gender, high diastolic blood pressure, low total
cholesterol or LDL-cholesterol, normal BMI, impaired
renal function, and high uric acid levels. Multivariate
analysis of factors that were associated with increased
prevalence of AF was performed and the results revealed
that the strongest association was old age followed by
male gender, low LDL-cholesterol and increased uric
acid levels (Table 2).
Since a number of patients had missing values for uric
acid. This may have decreased the statistical power of
Table 1 Baseline characteristics of patients (total number of
subjects = 13207)
Baseline variables n Mean ± SD or number (%)













SBP 13197 130.8 ± 16.3
DBP 13186 75.0 ± 10.8
TC 11635 190.7 ± 44.1
TG 11882 158.2 ± 92.8
HDL 11268 47.8 ± 13.7
LDL 11536 113.5 ± 37.4
BMI 11865 25.2 ± 4.49
GFR_EPI 12248 66.7 ± 23.9
Uric acid 5392 6.15 ± 1.95
SD standard deviation, DM diabetes mellitus, SBP systolic blood pressure, DBP
diastolic blood pressure, TC total cholesterol, TG triglyceride, HDL high density
lipoprotein cholesterol, LDL low density lipoprotein cholesterol, BMI body mass
index, GFR_EPI glomerular filtration rate by epidemiology collaboration formula
Krittayaphong et al. BMC Cardiovascular Disorders  (2016) 16:57 Page 3 of 7
the complete-cases analysis. We subsequently applied
imputations to handle the missing value and the results
of the multivariate analysis after imputation showed that
three of the four original independent associations with
AF remained significant (Table 2).
Table 3 showed the relationship between number of
these 4 factors and the Odds and 95 % CI of AF. The
Odds of AF increased from 1.64 in patients with only 1
association factor to 8.99 for those with all 4 factors
compared to those without any of these 4 factors.
We also collected the data on the history of ischemic
stroke. The prevalence of previous ischemic stroke in
this study was 3.8 %. AF was a significant and independ-
ent factor associated with ischemic stroke with the OR
and 95 % CI of 2.32 (1.64–3.29).
Discussion
Our study showed that prevalence of AF in Thai popula-
tion with hypertension was 3.46 %. The prevalence in-
creased in male, elderly, low LDL-cholesterol and high
Fig. 1 Prevalence of AF in men and women at different age groups
Fig. 2 Bivariate analysis factors affecting AF
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uric acid levels. This is the first report of prevalence of
AF in Thai population based on a nationally representa-
tive sample. Our study was systematically conducted and
employed stratified cluster sampling based on popula-
tion and hospital size.
AF represents a large burden to the population mainly
due to the embolic complication [17]. Ischemic stroke
related to AF has been reported to be more disabling
than stroke not related to AF [18]. It is one of the most
common sustained arrhythmias and more common in
the elderly population [1, 2]. Stroke prophylaxis strat-
egies have been shown to be very cost effective [19] al-
though the treatment might cause major bleeding and
intracranial bleeding. Anticoagulation is recommended
in patients with AF and at least one risk factor [3].
Previous reports indicate that prevalence of AF in
western populations is generally greater than Asian pop-
ulations [4, 6]. There was no clear explanation for this
but it could be related to genetic predisposition reported
by previous studies on specific polymorphisms that re-
lated to AF [20, 21]. We aimed to study prevalence of
AF in the Thai hypertensive population since hyperten-
sion is a common cardiovascular risk factor and predis-
poses individuals to AF [11]. Anticoagulant to prevent
stroke is recommended in AF patients in the setting of
hypertension [3, 18]. Therefore, prevalence of AF in our
study may represent an over-estimate in general popula-
tion, but is likely to be a valid estimate for the Thai
hypertensive population. Prevalence of AF in our study
was 3.46 % which is greater than 1.21 % and 1.3 % preva-
lence of AF in general population in Thailand [22, 23],
0.65 % for China [24], 0.56 % for Japan [25] and 0.95 %
and 1.2 % prevalence of AF in the United States and
United Kingdom [8, 26]. However, our results are compar-
able with those from a study conducted by Davies and col-
leagues which reported the prevalence of 5.1 % in male
and 2.6 % in female [27].
Univariate analysis of our study showed that factors as-
sociated with AF were old age, male gender, low total
cholesterol or LDL-cholesterol, normal BMI, impaired
renal function, and high uric acid levels. However, after
adjusting for confounding, only old age, male gender, low
LDL-cholesterol and high uric acid levels remained signifi-
cantly associated with AF, with elderly as the important
factor. Prevalence of AF increases with age due to degen-
erative process of the atrial muscle and conducting cells
[2, 28]. The results of our study are similar with those
conducted on both western and other Asian populations
[6]. The finding on more predominance in males is also
consistent with previous reports [8, 29]. We noticed a sig-
nificant interaction of age and gender on the prevalence of
AF. Male gender was more likely to have AF compared to
female in the age group less than 70 years but no such as-
sociation after the age of 70. This finding was not found in
previous reports from Europe [29] and United States [8].
However, similar interaction has been reported from
Taiwan [5]. Therefore, the effect of male gender on the in-
creased prevalence of AF in Asian population may dis-
appear after the age of 70 years. Renal impairment has
been reported as a risk factor in some previous studies
[14, 30]. From our study, however, although renal impair-
ment was associated with AF at the crude level, it did not
remain significant when adjusting for other covariates.
We do not have a clear explanation why AF was
related to low LDL-cholesterol in our study. Studies
about the impact of Hyperlipidemia on AF show mixed
results. Indeed, some reports indicate that hyperlipid-
emic patients have a lower risk of AF [14, 31], as in our
study. However, another study showed that hyperlipid-
emia had a higher risk of AF [24]. The relationship
between AF and low LDL-cholesterol in our study
should be interpreted with caution due to the cross-
sectional nature of our study. It is possible that patients
with AF may have dyslipidemia, and treatment with sta-
tins was not recorded in our dataset.
Table 2 Multivariate analysis of factors that had independent association with AF along with the prevalence of AF for complete
cases
Factors %AF ORcrude ORadj 95 % CI OR(IMP) 95%CI
Age ≥65 years 4.1 2.55*** 2.86*** 1.89–4.33 2.44*** 1.99–2.98
Male gender 3.6 1.26* 1.98** 1.35–2.91 0.86 0.71–1.04
LDL <100 mg/dl 4.0 1.74*** 1.87** 1.28–2.73 1.62*** 1.32–1.96
High uric acid level 3.2 1.46* 1.48* 1.02–2.17 1.26* 1.04–1.51
*p < 0.05, **p < 0.01, ***p < 0.001
ORadj odds ratio after adjusting for potential confounders, OR(IMP) odds ratio after imputating missing data, CI confidence interval, LDL low density lipoprotein cholesterol
Table 3 Relationship between numbers of independent factors
associated with atrial fibrillation and Odds of having atrial
fibrillation. Patient without any of these 4 factors were treated
as the reference group
Number of factors associated
with AF
OR 95 % CI P value
0 reference
1 1.64 1.07–2.51 0.022
2 2.46 1.66–3.63 <0.001
3 4.30 2.90–6.38 <0.001
4 8.99 5.02–16.07 <0.001
AF atrial fibrillation, OR Odds ratio, CI confidence interval
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For the association we identified between AF and hy-
peruricemia, there have been few studies to support our
findings. Although, some previous studies showed that
hyperuricemia is an independent risk factor for AF [32, 33].
It is postulated that hyperuricemia can have effect on the
inflammatory and fibrotic process [34] leading to an in-
creased atrial size and eventually AF [32] which may occur
with or without a preceding inflammatory process. Some
studies showed that treatment of hyperuricemia can pre-
vent inflammatory and fibrosis formation in certain disease
such as pericarditis [35, 36].
Results of our study have some clinical implications.
Our main objective was to get an accurate estimate of
prevalence of AF in hypertensive population. Our preva-
lence estimate 3.46 % AF in the hypertensive population
is high considering the malignant course of this disease
that might cause a serious thromboembolic stroke. We
demonstrate that there are other factors that could even
further increase the prevalence of AF with odds ratio as
high as 20 for certain combinations of the associated fac-
tors. For example, males older than 65 years of age with
an LDL less than 100 mg/dl and elevated uric acid have
a very high risk of AF. Regular monitoring with ECG or
teaching patients to feel the regularity of their pulse
should be considered in practice guideline [3]. Such an
approach may help reduce the number of serious strokes
related to AF by giving stroke prophylaxis treatment.
There were some limitations of our study. First, this
study did not initially plan to study ECG finding, and
collection of ECG data was incidental (if it was con-
tained in a patient’s medical record) and only 18.5 %
of patients had ECG data. Due to a slightly higher
proportion of males and a marginally older sample
patient with ECG, compared with those without ECG,
the prevalence of AF of 3.46 % may represent an
overestimate of prevalence in the Thai hypertensive
population. If we adjust for the small difference in
age and gender between patients with and without
ECG, the prevalence of AF for the whole population
(with and without ECG) would be 3.3 % if adjusting
for gender, 3.28 % if adjusting for age, and 3.15 % if
adjusting for both factors. Secondly, this study did
not have data on medications such as antihyperten-
sive medications, antithrombotic medication and sta-
tins. Lastly, this study is a cross-sectional study, not a
cohort study, so factors associated with AF cannot be
concluded to represent risk factors, only factors asso-
ciated with AF. However, the main strength of this
study is that this is s nationwide study and probable
one of the first in Southeast Asia region.
Conclusions
In conclusion, prevalence of AF in hypertensive popula-
tion in our study was 3.46 % which is higher than
prevalence of AF in the general community setting con-
sidered in most previous reports. The results from our
study are useful for future study of the management of AF.
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